AAAAAA

   
Results: 1-16 |
Results: 16

Authors: Sadler, BM Kozick, RJ Moore, T
Citation: Bm. Sadler et al., Bounds on bearing and symbol estimation with side information, IEEE SIGNAL, 49(4), 2001, pp. 822-834

Authors: Sadler, BM Piliero, PJ Preston, SL Lloyd, PP Lou, Y Stein, DS
Citation: Bm. Sadler et al., Pharmacokinetics and safety of amprenavir and ritonavir following multiple-dose, co-administration to healthy volunteers, AIDS, 15(8), 2001, pp. 1009-1018

Authors: Sadler, BM Chittick, GE Polk, RE Slain, D Kerkering, TM Studenberg, SD Lou, Y Moore, KHP Woolley, JL Stein, DS
Citation: Bm. Sadler et al., Metabolic disposition and pharmacokinetics of [C-14]-amprenavir, a human immunodeficiency virus type 1 (HIV-1) protease inhibitor, administered as a single oral dose to healthy male subjects, J CLIN PHAR, 41(4), 2001, pp. 386-396

Authors: Sadler, BM Gillotin, C Lou, Y Stein, DS
Citation: Bm. Sadler et al., In vivo effect of alpha(1)-acid glycoprotein on pharmacokinetics of amprenavir, a human immunodeficiency virus protease inhibitor, ANTIM AG CH, 45(3), 2001, pp. 852-856

Authors: Polk, RE Brophy, DF Israel, DS Patron, R Sadler, BM Chittick, GE Symonds, WT Lou, Y Kristoff, D Stein, DS
Citation: Re. Polk et al., Pharmacokinetic interaction between amprenavir and rifabutin or rifampin in healthy males, ANTIM AG CH, 45(2), 2001, pp. 502-508

Authors: Sadler, BM Gillotin, C Lou, Y Eron, JJ Lang, W Haubrich, R Stein, DS
Citation: Bm. Sadler et al., Pharmacokinetic study of human immunodeficiency virus protease inhibitors used in combination with amprenavir, ANTIM AG CH, 45(12), 2001, pp. 3663-3668

Authors: Sadler, BM Gillotin, C Lou, Y Stein, DS
Citation: Bm. Sadler et al., Pharmacokinetic and pharmacodynamic study of the human immunodeficiency virus protease inhibitor amprenavir after multiple oral dosing, ANTIM AG CH, 45(1), 2001, pp. 30-37

Authors: Kozick, RJ Sadler, BM
Citation: Rj. Kozick et Bm. Sadler, Maximum-likelihood array processing in non-Gaussian noise with Gaussian mixtures, IEEE SIGNAL, 48(12), 2000, pp. 3520-3535

Authors: Swami, A Sadler, BM
Citation: A. Swami et Bm. Sadler, Hierarchical digital modulation classification using cumulants, IEEE COMMUN, 48(3), 2000, pp. 416-429

Authors: Veronese, L Rautaureau, J Sadler, BM Gillotin, C Petite, JP Pillegand, B Delvaux, M Masliah, C Fosse, S Lou, Y Stein, DS
Citation: L. Veronese et al., Single-dose pharmacokinetics of amprenavir, a human immunodeficiency virustype 1 protease inhibitor, in subjects with normal or impaired hepatic function, ANTIM AG CH, 44(4), 2000, pp. 821-826

Authors: Brophy, DF Israel, DS Pastor, A Gillotin, C Chittick, GE Symonds, WT Lou, Y Sadler, BM Polk, RE
Citation: Df. Brophy et al., Pharmacokinetic interaction between amprenavir and clarithromycin in healthy male volunteers, ANTIM AG CH, 44(4), 2000, pp. 978-984

Authors: Sadler, BM Casey, SD
Citation: Bm. Sadler et Sd. Casey, Sinusoidal frequency estimation via sparse zero crossings, J FRANKL I, 337(2-3), 2000, pp. 131-145

Authors: Blum, RS Kozick, RJ Sadler, BM
Citation: Rs. Blum et al., An adaptive spatial diversity receiver for non-Gaussian interference and noise, IEEE SIGNAL, 47(8), 1999, pp. 2100-2111

Authors: Polk, RE Crouch, MA Israel, DS Pastor, A Sadler, BM Chittick, GE Symonds, WT Gouldin, W Lou, Y
Citation: Re. Polk et al., Pharmacokinetic interaction between ketoconazole and amprenavir after single doses in healthy men, PHARMACOTHE, 19(12), 1999, pp. 1378-1384

Authors: Sadler, BM Hanson, CD Chittick, GE Symonds, WT Roskell, NS
Citation: Bm. Sadler et al., Safety and pharmacokinetics of amprenavir (141W94), a human immunodeficiency virus (HIV) type 1 protease inhibitor, following oral administration of single doses to HIV-infected adults, ANTIM AG CH, 43(7), 1999, pp. 1686-1692

Authors: Sadler, BM Swami, A
Citation: Bm. Sadler et A. Swami, Analysis of multiscale products for step detection and estimation, IEEE INFO T, 45(3), 1999, pp. 1043-1051
Risultati: 1-16 |